GSK acquires oligonucleotide drug startup Elsie - BioPharma Dive

Retrieved on: 2024-06-06 19:41:37

Tags for this article:

Antisense RNA

Bepirovirsen

Hepatitis B

Therapeutic gene modulation

Biotechnology

Click the tags to see associated articles and topics

GSK acquires oligonucleotide drug startup Elsie - BioPharma Dive. View article details on hiswai:

Summary

The article discusses GSK's acquisition of Elsie Biotechnologies to advance its biopharma efforts, focusing on oligonucleotide drugs used for therapeutic gene modulation. Tags relate to technologies like Antisense RNA, Hepatitis B drug bepirovirsen, and broader biotech strategies.

Article found on: www.biopharmadive.com

View Original Article